Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66414-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- LDLR antibody
- Antibody type
- Monoclonal
- Description
- LDLR antibody (Cat. #66414-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A2A3
- Vial size
- 20ul, 150ul
Submitted references Nanoparticles for inducing Gaucher disease-like damage in cancer cells.
Large-Scale CRISPR Screen of LDLR Pathogenic Variants.
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models.
Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells.
Yue C, Lu W, Fan S, Huang Z, Yang J, Dong H, Zhang X, Shang Y, Lai W, Li D, Dong T, Yuan A, Wu J, Kang L, Hu Y
Nature nanotechnology 2024 Aug;19(8):1203-1215
Nature nanotechnology 2024 Aug;19(8):1203-1215
Large-Scale CRISPR Screen of LDLR Pathogenic Variants.
Li M, Ma L, Chen Y, Li J, Wang Y, You W, Yuan H, Tang X, Ouyang H, Pang D
Research (Washington, D.C.) 2023;6:0203
Research (Washington, D.C.) 2023;6:0203
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
White Z, Sun Z, Sauge E, Cox D, Donen G, Pechkovsky D, Straub V, Francis GA, Bernatchez P
Skeletal muscle 2022 Nov 29;12(1):25
Skeletal muscle 2022 Nov 29;12(1):25
AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models.
Sun SM, Xie ZF, Zhang YM, Zhang XW, Zhou CD, Yin JP, Yu YY, Cui SC, Jiang HW, Li TT, Li J, Nan FJ, Li JY
Acta pharmacologica Sinica 2021 Apr;42(4):585-592
Acta pharmacologica Sinica 2021 Apr;42(4):585-592
Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells.
Xiao J, Bai XQ, Liao L, Zhou M, Peng J, Xiang Q, Ren Z, Wen HY, Jiang ZS, Tang ZH, Wang MM, Liu LS
International journal of molecular medicine 2019 May;43(5):2055-2063
International journal of molecular medicine 2019 May;43(5):2055-2063
No comments: Submit comment
No validations: Submit validation data